Immediate Impact

34 standout
Sub-graph 1 of 13

Citing Papers

Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability
2024 Standout
Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics
2024 Standout
2 intermediate papers

Works of Christopher Polk being referenced

C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial
2022
Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections
2020

Author Peers

Author Last Decade Papers Cites
Christopher Polk 36 77 3 111 83 17 218
Safia Kuriakose 72 95 4 119 98 16 235
Raja Shekar 76 93 12 38 73 14 295
Lucia Diella 65 69 68 146 122 28 299
Dominique Merrien 66 60 3 48 37 17 233
Paola Della Siega 106 87 6 81 105 19 267
Ilaria De Benedetto 117 88 8 52 50 25 260
Angeliki M. Andrianaki 90 111 74 29 12 232
Stefania Artioli 50 133 18 119 68 17 279
Carlos Mejía-Villatoro 65 46 61 19 10 134
Sirawat Srichatrapimuk 132 75 22 40 19 22 257

All Works

Loading papers...

Rankless by CCL
2026